Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

793.01
+2.360.30%
Post-market: 791.86-1.1500-0.15%19:59 EDT
Volume:2.85M
Turnover:2.24B
Market Cap:751.56B
PE:64.53
High:795.73
Open:786.35
Low:777.20
Close:790.65
Loading ...

Rznomics Enters Global Licensing Agreement With Eli Lilly for Rna-Editing Therapeutics

THOMSON REUTERS
·
15 May

Rznomics: Upfront Payment Was Not Disclosed

THOMSON REUTERS
·
15 May

Rznomics: IF Lilly Exercises All Available Options Under Agreement, Total Deal Value Could Reach More Than $1.3 Bln

THOMSON REUTERS
·
15 May

Analysts Conflicted on These Healthcare Names: Kezar Life Sciences (KZR), Eli Lilly & Co (LLY) and Becton Dickinson (BDX)

TIPRANKS
·
15 May

Eli Lilly & Co. Stock Slides 4.1%, Underperforms Competitors

Dow Jones
·
15 May

Mixed options sentiment in Eli Lilly (LLY), with shares down $-29.65 (-3.97%) near $716.41

TIPRANKS
·
15 May

Roche says Trump's drug price order threatens its $50 billion US investment plans

Reuters
·
14 May

Novo Nordisk and Septerna Say They Will Collaborate on Developing Medicines for Obesity, Type 2 Diabetes

THOMSON REUTERS
·
14 May

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments

Reuters
·
14 May

Deal Worth up to $2.2 Billion for Septerna, the Companies Say

THOMSON REUTERS
·
14 May

Quality Growth Stocks Make Sense for an Uncertain Economy -- Barrons.com

Dow Jones
·
14 May

Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump's Executive Order. -- Barrons.com

Dow Jones
·
13 May

Lilly Canada: Mounjaro Kwikpen Is NOW Available by Prescription Across Canada

THOMSON REUTERS
·
13 May

Eli Lilly & Co (LLY) Gets a Hold from Evercore ISI

TIPRANKS
·
13 May

These Stocks Moved the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More -- Barrons.com

Dow Jones
·
13 May

Trump calls out weight-loss drugs as target of price-cut push

Reuters
·
13 May

Trump Signs Order Aiming to Cut Some U.S. Drug Prices to Match Lower Ones Abroad

Tiger Newspress
·
12 May

Trump Executive Order Could Reshape How Americans Pay for Drugs. Why It Isn't Bad for Pharma Stocks. -- Barrons.com

Dow Jones
·
12 May

Trump Executive Order Could Reshape How Americans Pay for Drugs. It’s Not Bad for Pharma

Tiger Newspress
·
12 May

Pfizer up 2.8%, Eli Lilly up 2.9%, Merck up 4.5%, Gilead Sciences up 4.3%, Abbvie up 1.4%

THOMSON REUTERS
·
12 May